BIOTECH, CANNABIS
Bin Huang
President & CEO,
Emerald Health Therapeutics
- President & CEO, Emerald Health Therapeutics
- Former CEO, Cytovax Biotechnologies
- Holds a PhD in Plant Cell Biology from the University of East Anglia, UK
Follow
About Bin
Bin Huang is an executive leader with over 30 years of experience in life sciences. Ms. Huang's career began with Allelix Crop Technologies, where she spent six years as a plant research scientist. For a number of years Ms. Huang was the president and CEO of Cytovax Biotechnologies, a Canadian biotechnology company. Following that, she led WEX Pharmaceuticals, a subsidiary of publicly listed CK Life Sciences International (Holdings) Inc., as president and CEO. Ms. Huang has a PhD in Plant Cell Biology from the University of East Anglia, UK and an MBA from the University of Toronto.
Bin's Videos
The Canadian cannabis industry continues to lead the global movement and these companies are positioned to see massive growth when the recreational market opens in 2018. From Australia to Uruguay, form Germany to Colombia, Canadian Licensed producers are capitalizing on what has become a global opportunity. The landscape of the cannabis industry has changed and this panel of experts features Canadian cannabis executives that are capitalizing on the global cannabis industry.
Bin Huang
CANNABIS
49:45
